Company intelligence / Profile preview

papimi

Vienna, Vienna, Austriapapimi.com ↗

Ownership: Private
Development stage: Commercial

Overview

The papimi device, based on pulsed electromagnetic field technology, claims to accelerate recovery from injuries, reduce pain and inflammation, and support general well-being. It has been used in human and veterinary medicine for over three decades but lacks regulatory approval in the US/Canada due to safety/efficacy concerns[1][4].

Therapeutic areas: OtherImmunologyNeurology
Modalities: Device (Pulsed electromagnetic field therapy)Non-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on papimi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on papimi.

Explore the full profile